CellTiter-Glo Reagent was added at a ratio of 1:1
If you are experiencing minimal side effects at this level and not seeing the results you want, you likely have room to escalate
Top-selling drug charts in 2025H1 show GLP-1 agonists displacing traditional blockbusters, reflecting how obesity and diabetes treatments have become huge revenue drivers
Cost: 8,000 12,000 per session Final IV drip selection and pricing are confirmed only after medical assessment to ensure safety, clinical appropriateness, and individualised dosing
The results have been difficult to argue with, as many users have shed a substantial amount in a relatively short period of time, even if the side effects can occasionally be on the unusual side
Pregnancy/Nursing: Tirzepatide is not recommended for those who are pregnant or planning to become pregnant in the near future